Therapeutic Nuclear Medicines and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Therapeutic Nuclear Medicines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Therapeutic Nuclear Medicines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Therapeutic Nuclear Medicines Overall Market Size
2.1 Global Therapeutic Nuclear Medicines Market Size: 2022 VS 2029
2.2 Global Therapeutic Nuclear Medicines Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Therapeutic Nuclear Medicines Sales: 2018-2029
3 Company Landscape
3.1 Top Therapeutic Nuclear Medicines Players in Global Market
3.2 Top Global Therapeutic Nuclear Medicines Companies Ranked by Revenue
3.3 Global Therapeutic Nuclear Medicines Revenue by Companies
3.4 Global Therapeutic Nuclear Medicines Sales by Companies
3.5 Global Therapeutic Nuclear Medicines Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Therapeutic Nuclear Medicines Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Therapeutic Nuclear Medicines Product Type
3.8 Tier 1, Tier 2 and Tier 3 Therapeutic Nuclear Medicines Players in Global Market
3.8.1 List of Global Tier 1 Therapeutic Nuclear Medicines Companies
3.8.2 List of Global Tier 2 and Tier 3 Therapeutic Nuclear Medicines Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Therapeutic Nuclear Medicines Market Size Markets, 2022 & 2029
4.1.2 Radium-223
4.1.3 Lutetium-177
4.1.4 Iodine-131
4.1.5 Other
4.2 By Type - Global Therapeutic Nuclear Medicines Revenue & Forecasts
4.2.1 By Type - Global Therapeutic Nuclear Medicines Revenue, 2018-2023
4.2.2 By Type - Global Therapeutic Nuclear Medicines Revenue, 2024-2029
4.2.3 By Type - Global Therapeutic Nuclear Medicines Revenue Market Share, 2018-2029
4.3 By Type - Global Therapeutic Nuclear Medicines Sales & Forecasts
4.3.1 By Type - Global Therapeutic Nuclear Medicines Sales, 2018-2023
4.3.2 By Type - Global Therapeutic Nuclear Medicines Sales, 2024-2029
4.3.3 By Type - Global Therapeutic Nuclear Medicines Sales Market Share, 2018-2029
4.4 By Type - Global Therapeutic Nuclear Medicines Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Therapeutic Nuclear Medicines Market Size, 2022 & 2029
5.1.2 Thyroid
5.1.3 Bone Metastasis
5.1.4 Lymphoma
5.1.5 Other
5.2 By Application - Global Therapeutic Nuclear Medicines Revenue & Forecasts
5.2.1 By Application - Global Therapeutic Nuclear Medicines Revenue, 2018-2023
5.2.2 By Application - Global Therapeutic Nuclear Medicines Revenue, 2024-2029
5.2.3 By Application - Global Therapeutic Nuclear Medicines Revenue Market Share, 2018-2029
5.3 By Application - Global Therapeutic Nuclear Medicines Sales & Forecasts
5.3.1 By Application - Global Therapeutic Nuclear Medicines Sales, 2018-2023
5.3.2 By Application - Global Therapeutic Nuclear Medicines Sales, 2024-2029
5.3.3 By Application - Global Therapeutic Nuclear Medicines Sales Market Share, 2018-2029
5.4 By Application - Global Therapeutic Nuclear Medicines Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Therapeutic Nuclear Medicines Market Size, 2022 & 2029
6.2 By Region - Global Therapeutic Nuclear Medicines Revenue & Forecasts
6.2.1 By Region - Global Therapeutic Nuclear Medicines Revenue, 2018-2023
6.2.2 By Region - Global Therapeutic Nuclear Medicines Revenue, 2024-2029
6.2.3 By Region - Global Therapeutic Nuclear Medicines Revenue Market Share, 2018-2029
6.3 By Region - Global Therapeutic Nuclear Medicines Sales & Forecasts
6.3.1 By Region - Global Therapeutic Nuclear Medicines Sales, 2018-2023
6.3.2 By Region - Global Therapeutic Nuclear Medicines Sales, 2024-2029
6.3.3 By Region - Global Therapeutic Nuclear Medicines Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Therapeutic Nuclear Medicines Revenue, 2018-2029
6.4.2 By Country - North America Therapeutic Nuclear Medicines Sales, 2018-2029
6.4.3 US Therapeutic Nuclear Medicines Market Size, 2018-2029
6.4.4 Canada Therapeutic Nuclear Medicines Market Size, 2018-2029
6.4.5 Mexico Therapeutic Nuclear Medicines Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Therapeutic Nuclear Medicines Revenue, 2018-2029
6.5.2 By Country - Europe Therapeutic Nuclear Medicines Sales, 2018-2029
6.5.3 Germany Therapeutic Nuclear Medicines Market Size, 2018-2029
6.5.4 France Therapeutic Nuclear Medicines Market Size, 2018-2029
6.5.5 U.K. Therapeutic Nuclear Medicines Market Size, 2018-2029
6.5.6 Italy Therapeutic Nuclear Medicines Market Size, 2018-2029
6.5.7 Russia Therapeutic Nuclear Medicines Market Size, 2018-2029
6.5.8 Nordic Countries Therapeutic Nuclear Medicines Market Size, 2018-2029
6.5.9 Benelux Therapeutic Nuclear Medicines Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Therapeutic Nuclear Medicines Revenue, 2018-2029
6.6.2 By Region - Asia Therapeutic Nuclear Medicines Sales, 2018-2029
6.6.3 China Therapeutic Nuclear Medicines Market Size, 2018-2029
6.6.4 Japan Therapeutic Nuclear Medicines Market Size, 2018-2029
6.6.5 South Korea Therapeutic Nuclear Medicines Market Size, 2018-2029
6.6.6 Southeast Asia Therapeutic Nuclear Medicines Market Size, 2018-2029
6.6.7 India Therapeutic Nuclear Medicines Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Therapeutic Nuclear Medicines Revenue, 2018-2029
6.7.2 By Country - South America Therapeutic Nuclear Medicines Sales, 2018-2029
6.7.3 Brazil Therapeutic Nuclear Medicines Market Size, 2018-2029
6.7.4 Argentina Therapeutic Nuclear Medicines Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Therapeutic Nuclear Medicines Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Therapeutic Nuclear Medicines Sales, 2018-2029
6.8.3 Turkey Therapeutic Nuclear Medicines Market Size, 2018-2029
6.8.4 Israel Therapeutic Nuclear Medicines Market Size, 2018-2029
6.8.5 Saudi Arabia Therapeutic Nuclear Medicines Market Size, 2018-2029
6.8.6 UAE Therapeutic Nuclear Medicines Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Novartis AG
7.1.1 Novartis AG Company Summary
7.1.2 Novartis AG Business Overview
7.1.3 Novartis AG Therapeutic Nuclear Medicines Major Product Offerings
7.1.4 Novartis AG Therapeutic Nuclear Medicines Sales and Revenue in Global (2018-2023)
7.1.5 Novartis AG Key News & Latest Developments
7.2 Bayer
7.2.1 Bayer Company Summary
7.2.2 Bayer Business Overview
7.2.3 Bayer Therapeutic Nuclear Medicines Major Product Offerings
7.2.4 Bayer Therapeutic Nuclear Medicines Sales and Revenue in Global (2018-2023)
7.2.5 Bayer Key News & Latest Developments
7.3 China Isotope & Radiation
7.3.1 China Isotope & Radiation Company Summary
7.3.2 China Isotope & Radiation Business Overview
7.3.3 China Isotope & Radiation Therapeutic Nuclear Medicines Major Product Offerings
7.3.4 China Isotope & Radiation Therapeutic Nuclear Medicines Sales and Revenue in Global (2018-2023)
7.3.5 China Isotope & Radiation Key News & Latest Developments
7.4 Q BioMed
7.4.1 Q BioMed Company Summary
7.4.2 Q BioMed Business Overview
7.4.3 Q BioMed Therapeutic Nuclear Medicines Major Product Offerings
7.4.4 Q BioMed Therapeutic Nuclear Medicines Sales and Revenue in Global (2018-2023)
7.4.5 Q BioMed Key News & Latest Developments
7.5 Curium Pharmaceuticals
7.5.1 Curium Pharmaceuticals Company Summary
7.5.2 Curium Pharmaceuticals Business Overview
7.5.3 Curium Pharmaceuticals Therapeutic Nuclear Medicines Major Product Offerings
7.5.4 Curium Pharmaceuticals Therapeutic Nuclear Medicines Sales and Revenue in Global (2018-2023)
7.5.5 Curium Pharmaceuticals Key News & Latest Developments
7.6 Jubilant DraxImage
7.6.1 Jubilant DraxImage Company Summary
7.6.2 Jubilant DraxImage Business Overview
7.6.3 Jubilant DraxImage Therapeutic Nuclear Medicines Major Product Offerings
7.6.4 Jubilant DraxImage Therapeutic Nuclear Medicines Sales and Revenue in Global (2018-2023)
7.6.5 Jubilant DraxImage Key News & Latest Developments
7.7 Dongcheng
7.7.1 Dongcheng Company Summary
7.7.2 Dongcheng Business Overview
7.7.3 Dongcheng Therapeutic Nuclear Medicines Major Product Offerings
7.7.4 Dongcheng Therapeutic Nuclear Medicines Sales and Revenue in Global (2018-2023)
7.7.5 Dongcheng Key News & Latest Developments
7.8 Lantheus
7.8.1 Lantheus Company Summary
7.8.2 Lantheus Business Overview
7.8.3 Lantheus Therapeutic Nuclear Medicines Major Product Offerings
7.8.4 Lantheus Therapeutic Nuclear Medicines Sales and Revenue in Global (2018-2023)
7.8.5 Lantheus Key News & Latest Developments
7.9 Acrotech Biopharma.
7.9.1 Acrotech Biopharma. Company Summary
7.9.2 Acrotech Biopharma. Business Overview
7.9.3 Acrotech Biopharma. Therapeutic Nuclear Medicines Major Product Offerings
7.9.4 Acrotech Biopharma. Therapeutic Nuclear Medicines Sales and Revenue in Global (2018-2023)
7.9.5 Acrotech Biopharma. Key News & Latest Developments
7.10 Progenics Pharmaceuticals
7.10.1 Progenics Pharmaceuticals Company Summary
7.10.2 Progenics Pharmaceuticals Business Overview
7.10.3 Progenics Pharmaceuticals Therapeutic Nuclear Medicines Major Product Offerings
7.10.4 Progenics Pharmaceuticals Therapeutic Nuclear Medicines Sales and Revenue in Global (2018-2023)
7.10.5 Progenics Pharmaceuticals Key News & Latest Developments
7.11 International Isotopes
7.11.1 International Isotopes Company Summary
7.11.2 International Isotopes Therapeutic Nuclear Medicines Business Overview
7.11.3 International Isotopes Therapeutic Nuclear Medicines Major Product Offerings
7.11.4 International Isotopes Therapeutic Nuclear Medicines Sales and Revenue in Global (2018-2023)
7.11.5 International Isotopes Key News & Latest Developments
8 Global Therapeutic Nuclear Medicines Production Capacity, Analysis
8.1 Global Therapeutic Nuclear Medicines Production Capacity, 2018-2029
8.2 Therapeutic Nuclear Medicines Production Capacity of Key Manufacturers in Global Market
8.3 Global Therapeutic Nuclear Medicines Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Therapeutic Nuclear Medicines Supply Chain Analysis
10.1 Therapeutic Nuclear Medicines Industry Value Chain
10.2 Therapeutic Nuclear Medicines Upstream Market
10.3 Therapeutic Nuclear Medicines Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Therapeutic Nuclear Medicines Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Therapeutic Nuclear Medicines in Global Market
Table 2. Top Therapeutic Nuclear Medicines Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Therapeutic Nuclear Medicines Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Therapeutic Nuclear Medicines Revenue Share by Companies, 2018-2023
Table 5. Global Therapeutic Nuclear Medicines Sales by Companies, (K Units), 2018-2023
Table 6. Global Therapeutic Nuclear Medicines Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Therapeutic Nuclear Medicines Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Therapeutic Nuclear Medicines Product Type
Table 9. List of Global Tier 1 Therapeutic Nuclear Medicines Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Therapeutic Nuclear Medicines Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Therapeutic Nuclear Medicines Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Therapeutic Nuclear Medicines Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Therapeutic Nuclear Medicines Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Therapeutic Nuclear Medicines Sales (K Units), 2018-2023
Table 15. By Type - Global Therapeutic Nuclear Medicines Sales (K Units), 2024-2029
Table 16. By Application ? Global Therapeutic Nuclear Medicines Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Therapeutic Nuclear Medicines Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Therapeutic Nuclear Medicines Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Therapeutic Nuclear Medicines Sales (K Units), 2018-2023
Table 20. By Application - Global Therapeutic Nuclear Medicines Sales (K Units), 2024-2029
Table 21. By Region ? Global Therapeutic Nuclear Medicines Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Therapeutic Nuclear Medicines Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Therapeutic Nuclear Medicines Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Therapeutic Nuclear Medicines Sales (K Units), 2018-2023
Table 25. By Region - Global Therapeutic Nuclear Medicines Sales (K Units), 2024-2029
Table 26. By Country - North America Therapeutic Nuclear Medicines Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Therapeutic Nuclear Medicines Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Therapeutic Nuclear Medicines Sales, (K Units), 2018-2023
Table 29. By Country - North America Therapeutic Nuclear Medicines Sales, (K Units), 2024-2029
Table 30. By Country - Europe Therapeutic Nuclear Medicines Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Therapeutic Nuclear Medicines Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Therapeutic Nuclear Medicines Sales, (K Units), 2018-2023
Table 33. By Country - Europe Therapeutic Nuclear Medicines Sales, (K Units), 2024-2029
Table 34. By Region - Asia Therapeutic Nuclear Medicines Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Therapeutic Nuclear Medicines Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Therapeutic Nuclear Medicines Sales, (K Units), 2018-2023
Table 37. By Region - Asia Therapeutic Nuclear Medicines Sales, (K Units), 2024-2029
Table 38. By Country - South America Therapeutic Nuclear Medicines Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Therapeutic Nuclear Medicines Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Therapeutic Nuclear Medicines Sales, (K Units), 2018-2023
Table 41. By Country - South America Therapeutic Nuclear Medicines Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Therapeutic Nuclear Medicines Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Therapeutic Nuclear Medicines Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Therapeutic Nuclear Medicines Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Therapeutic Nuclear Medicines Sales, (K Units), 2024-2029
Table 46. Novartis AG Company Summary
Table 47. Novartis AG Therapeutic Nuclear Medicines Product Offerings
Table 48. Novartis AG Therapeutic Nuclear Medicines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Novartis AG Key News & Latest Developments
Table 50. Bayer Company Summary
Table 51. Bayer Therapeutic Nuclear Medicines Product Offerings
Table 52. Bayer Therapeutic Nuclear Medicines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Bayer Key News & Latest Developments
Table 54. China Isotope & Radiation Company Summary
Table 55. China Isotope & Radiation Therapeutic Nuclear Medicines Product Offerings
Table 56. China Isotope & Radiation Therapeutic Nuclear Medicines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. China Isotope & Radiation Key News & Latest Developments
Table 58. Q BioMed Company Summary
Table 59. Q BioMed Therapeutic Nuclear Medicines Product Offerings
Table 60. Q BioMed Therapeutic Nuclear Medicines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. Q BioMed Key News & Latest Developments
Table 62. Curium Pharmaceuticals Company Summary
Table 63. Curium Pharmaceuticals Therapeutic Nuclear Medicines Product Offerings
Table 64. Curium Pharmaceuticals Therapeutic Nuclear Medicines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. Curium Pharmaceuticals Key News & Latest Developments
Table 66. Jubilant DraxImage Company Summary
Table 67. Jubilant DraxImage Therapeutic Nuclear Medicines Product Offerings
Table 68. Jubilant DraxImage Therapeutic Nuclear Medicines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. Jubilant DraxImage Key News & Latest Developments
Table 70. Dongcheng Company Summary
Table 71. Dongcheng Therapeutic Nuclear Medicines Product Offerings
Table 72. Dongcheng Therapeutic Nuclear Medicines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 73. Dongcheng Key News & Latest Developments
Table 74. Lantheus Company Summary
Table 75. Lantheus Therapeutic Nuclear Medicines Product Offerings
Table 76. Lantheus Therapeutic Nuclear Medicines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 77. Lantheus Key News & Latest Developments
Table 78. Acrotech Biopharma. Company Summary
Table 79. Acrotech Biopharma. Therapeutic Nuclear Medicines Product Offerings
Table 80. Acrotech Biopharma. Therapeutic Nuclear Medicines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 81. Acrotech Biopharma. Key News & Latest Developments
Table 82. Progenics Pharmaceuticals Company Summary
Table 83. Progenics Pharmaceuticals Therapeutic Nuclear Medicines Product Offerings
Table 84. Progenics Pharmaceuticals Therapeutic Nuclear Medicines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 85. Progenics Pharmaceuticals Key News & Latest Developments
Table 86. International Isotopes Company Summary
Table 87. International Isotopes Therapeutic Nuclear Medicines Product Offerings
Table 88. International Isotopes Therapeutic Nuclear Medicines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 89. International Isotopes Key News & Latest Developments
Table 90. Therapeutic Nuclear Medicines Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 91. Global Therapeutic Nuclear Medicines Capacity Market Share of Key Manufacturers, 2021-2023
Table 92. Global Therapeutic Nuclear Medicines Production by Region, 2018-2023 (K Units)
Table 93. Global Therapeutic Nuclear Medicines Production by Region, 2024-2029 (K Units)
Table 94. Therapeutic Nuclear Medicines Market Opportunities & Trends in Global Market
Table 95. Therapeutic Nuclear Medicines Market Drivers in Global Market
Table 96. Therapeutic Nuclear Medicines Market Restraints in Global Market
Table 97. Therapeutic Nuclear Medicines Raw Materials
Table 98. Therapeutic Nuclear Medicines Raw Materials Suppliers in Global Market
Table 99. Typical Therapeutic Nuclear Medicines Downstream
Table 100. Therapeutic Nuclear Medicines Downstream Clients in Global Market
Table 101. Therapeutic Nuclear Medicines Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Therapeutic Nuclear Medicines Segment by Type in 2022
Figure 2. Therapeutic Nuclear Medicines Segment by Application in 2022
Figure 3. Global Therapeutic Nuclear Medicines Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Therapeutic Nuclear Medicines Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Therapeutic Nuclear Medicines Revenue, 2018-2029 (US$, Mn)
Figure 7. Therapeutic Nuclear Medicines Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Therapeutic Nuclear Medicines Revenue in 2022
Figure 9. By Type - Global Therapeutic Nuclear Medicines Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Therapeutic Nuclear Medicines Revenue Market Share, 2018-2029
Figure 11. By Type - Global Therapeutic Nuclear Medicines Sales Market Share, 2018-2029
Figure 12. By Type - Global Therapeutic Nuclear Medicines Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Therapeutic Nuclear Medicines Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Therapeutic Nuclear Medicines Revenue Market Share, 2018-2029
Figure 15. By Application - Global Therapeutic Nuclear Medicines Sales Market Share, 2018-2029
Figure 16. By Application - Global Therapeutic Nuclear Medicines Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Therapeutic Nuclear Medicines Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Therapeutic Nuclear Medicines Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Therapeutic Nuclear Medicines Revenue Market Share, 2018-2029
Figure 20. By Region - Global Therapeutic Nuclear Medicines Sales Market Share, 2018-2029
Figure 21. By Country - North America Therapeutic Nuclear Medicines Revenue Market Share, 2018-2029
Figure 22. By Country - North America Therapeutic Nuclear Medicines Sales Market Share, 2018-2029
Figure 23. US Therapeutic Nuclear Medicines Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Therapeutic Nuclear Medicines Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Therapeutic Nuclear Medicines Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Therapeutic Nuclear Medicines Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Therapeutic Nuclear Medicines Sales Market Share, 2018-2029
Figure 28. Germany Therapeutic Nuclear Medicines Revenue, (US$, Mn), 2018-2029
Figure 29. France Therapeutic Nuclear Medicines Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Therapeutic Nuclear Medicines Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Therapeutic Nuclear Medicines Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Therapeutic Nuclear Medicines Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Therapeutic Nuclear Medicines Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Therapeutic Nuclear Medicines Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Therapeutic Nuclear Medicines Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Therapeutic Nuclear Medicines Sales Market Share, 2018-2029
Figure 37. China Therapeutic Nuclear Medicines Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Therapeutic Nuclear Medicines Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Therapeutic Nuclear Medicines Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Therapeutic Nuclear Medicines Revenue, (US$, Mn), 2018-2029
Figure 41. India Therapeutic Nuclear Medicines Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Therapeutic Nuclear Medicines Revenue Market Share, 2018-2029
Figure 43. By Country - South America Therapeutic Nuclear Medicines Sales Market Share, 2018-2029
Figure 44. Brazil Therapeutic Nuclear Medicines Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Therapeutic Nuclear Medicines Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Therapeutic Nuclear Medicines Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Therapeutic Nuclear Medicines Sales Market Share, 2018-2029
Figure 48. Turkey Therapeutic Nuclear Medicines Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Therapeutic Nuclear Medicines Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Therapeutic Nuclear Medicines Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Therapeutic Nuclear Medicines Revenue, (US$, Mn), 2018-2029
Figure 52. Global Therapeutic Nuclear Medicines Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Therapeutic Nuclear Medicines by Region, 2022 VS 2029
Figure 54. Therapeutic Nuclear Medicines Industry Value Chain
Figure 55. Marketing Channels